{
  "symbol": "MO",
  "year": 2025,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1832,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.13
  },
  "top_positive": [
    {
      "sent": "The fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates were as follows: (in billions) June 30, 2025 December 31, 2024 Fair value $ 23.0 $ 22.7 Decrease in fair value from a 1% increase in market interest rates 1.8 1.7 Increase in fair value from a 1% decrease in market interest rates 2.0 2.0 We expect interest rates on borrowings under our Credit Agreement to be based on the Term Secured Overnight Financing Rate, plus a percentage based on the higher of the ratings of\nu should not consider the foregoing list to be complete.",
      "score": 0.9914
    },
    {
      "sent": "The fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates were as follows: (in billions) June 30, 2025 December 31, 2024 Fair value $ 23.0 $ 22.7 Decrease in fair value from a 1% increase in market interest rates 1.8 1.7 Increase in fair value from a 1% decrease in market interest rates 2.0 2.0 We expect interest rates on borrowings under our Credit Agreement to be based on the Term Secured Overnight Financing Rate, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody\u2019s and S&P.",
      "score": 0.9893
    },
    {
      "sent": "37 Table of Contents Consolidated Results of Operations for the Six Months Ended June 30, 2025 The changes in net earnings and diluted EPS for the six months ended June 30, 2025, from the six months ended June 30, 2024, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the six months ended June 30, 2024 $ 5,932 $ 3.41 2024 NPM Adjustment Items (5) \u2014 2024 Acquisition and disposition-related items (1,882) (1.09) 2024 Asset impairment, exit and implementation costs 264 0.15 2024 Tobacco and health and certain other litigation items 52 0.03 2024 Amortization of intangibles 54 0.03 2024 ABI-related special items (48) (0.02) 2024 Cronos-related special items 19 0.01 2024 Income tax items (52) (0.03) Subtotal 2024 special items (1) (1,598) (0.92) 2025 Acquisition and disposition-related items (77) (0.05) 2025 Asset impairment, exit and implementation costs (896) (0.53) 2025 Tobacco and health and certain other litigation items (34) (0.02) 2025 Amortization of intangibles (62) (0.04) 2025 ABI-related special items (1) \u2014 2025 Cronos-related special items 16 0.01 2025 Income tax items (13) \u2014 Subtotal 2025 special items (1,067) (0.63) Fewer shares outstanding \u2014 0.08 Change in tax rate 60 0.03 Operations 128 0.07 For the six months ended June 30, 2025 $ 3,455 $ 2.04 2025 Reported Net Earnings and Reported Diluted EPS $ 3,455 $ 2.04 2024 Reported Net Earnings and Reported Diluted EPS $ 5,932 $ 3.41 % Change (41.8) % (40.2) % 2025 Adjusted Net Earnings and Adjusted Diluted EPS $ 4,522 $ 2.67 2024 Adjusted Net Earnings and Adjusted Diluted EPS $ 4,334 $ 2.49 % Change 4.3 % 7.2 % (1) Prior period amounts have been recast to conform with current period presentation for amortization of intangibles, which we did not previously identify as a special item and we now exclude from our adjusted financial measures.",
      "score": 0.9846
    }
  ],
  "top_negative": [
    {
      "sent": "Smoking and Health Litigation Overview: Plaintiffs\u2019 allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to\ntobacco subsidiaries.",
      "score": -0.9584
    },
    {
      "sent": "(4) Includes as of July28, 2025, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "(4) Includes as of July28, 2025, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    }
  ],
  "forward_snippets": [
    "\u25aa Share Repurchases: In January 2025, our Board of Directors (\u201cBoard of Directors\u201d or \u201cBoard\u201d) authorized a new $ 1.0 billion share repurchase program (\u201cJanuary 2025 share repurchase program\u201d), which we expect to complete by December 31, 2025.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15.",
    "New Accounting Guidance Not Yet Adopted .",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15.",
    "New Accounting Guidance Not Yet Adopted ."
  ],
  "curated_text": "Symbol: MO. Year: 2025. Period: Q1. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: The fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates were as follows: (in billions) June 30, 2025 December 31, 2024 Fair value $ 23.0 $ 22.7 Decrease in fair value from a 1% increase in market interest rates 1.8 1.7 Increase in fair value from a 1% decrease in market interest rates 2.0 2.0 We expect interest rates on borrowings under our Credit Agreement to be based on the Term Secured Overnight Financing Rate, plus a percentage based on the higher of the ratings of\nu should not consider the foregoing list to be complete. The fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates were as follows: (in billions) June 30, 2025 December 31, 2024 Fair value $ 23.0 $ 22.7 Decrease in fair value from a 1% increase in market interest rates 1.8 1.7 Increase in fair value from a 1% decrease in market interest rates 2.0 2.0 We expect interest rates on borrowings under our Credit Agreement to be based on the Term Secured Overnight Financing Rate, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody\u2019s and S&P. 37 Table of Contents Consolidated Results of Operations for the Six Months Ended June 30, 2025 The changes in net earnings and diluted EPS for the six months ended June 30, 2025, from the six months ended June 30, 2024, were due primarily to the following: (in millions, except per share data) Net Earnings Diluted EPS For the six months ended June 30, 2024 $ 5,932 $ 3.41 2024 NPM Adjustment Items (5) \u2014 2024 Acquisition and disposition-related items (1,882) (1.09) 2024 Asset impairment, exit and implementation costs 264 0.15 2024 Tobacco and health and certain other litigation items 52 0.03 2024 Amortization of intangibles 54 0.03 2024 ABI-related special items (48) (0.02) 2024 Cronos-related special items 19 0.01 2024 Income tax items (52) (0.03) Subtotal 2024 special items (1) (1,598) (0.92) 2025 Acquisition and disposition-related items (77) (0.05) 2025 Asset impairment, exit and implementation costs (896) (0.53) 2025 Tobacco and health and certain other litigation items (34) (0.02) 2025 Amortization of intangibles (62) (0.04) 2025 ABI-related special items (1) \u2014 2025 Cronos-related special items 16 0.01 2025 Income tax items (13) \u2014 Subtotal 2025 special items (1,067) (0.63) Fewer shares outstanding \u2014 0.08 Change in tax rate 60 0.03 Operations 128 0.07 For the six months ended June 30, 2025 $ 3,455 $ 2.04 2025 Reported Net Earnings and Reported Diluted EPS $ 3,455 $ 2.04 2024 Reported Net Earnings and Reported Diluted EPS $ 5,932 $ 3.41 % Change (41.8) % (40.2) % 2025 Adjusted Net Earnings and Adjusted Diluted EPS $ 4,522 $ 2.67 2024 Adjusted Net Earnings and Adjusted Diluted EPS $ 4,334 $ 2.49 % Change 4.3 % 7.2 % (1) Prior period amounts have been recast to conform with current period presentation for amortization of intangibles, which we did not previously identify as a special item and we now exclude from our adjusted financial measures. Top negative sentences: Smoking and Health Litigation Overview: Plaintiffs\u2019 allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to\ntobacco subsidiaries. (4) Includes as of July28, 2025, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. (4) Includes as of July28, 2025, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. Forward-looking snippets: \u25aa Share Repurchases: In January 2025, our Board of Directors (\u201cBoard of Directors\u201d or \u201cBoard\u201d) authorized a new $ 1.0 billion share repurchase program (\u201cJanuary 2025 share repurchase program\u201d), which we expect to complete by December 31, 2025. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15. New Accounting Guidance Not Yet Adopted . For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 15. New Accounting Guidance Not Yet Adopted ."
}